These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 32398334)
21. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844 [TBL] [Abstract][Full Text] [Related]
22. Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis. Cristea IA; Gentili C; Pietrini P; Cuijpers P Br J Psychiatry; 2017 Jan; 210(1):16-23. PubMed ID: 27810891 [TBL] [Abstract][Full Text] [Related]
23. Impact of industry collaboration on randomised controlled trials in oncology. Linker A; Yang A; Roper N; Whitaker E; Korenstein D Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518 [TBL] [Abstract][Full Text] [Related]
24. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. Hakoum MB; Anouti S; Al-Gibbawi M; Abou-Jaoude EA; Hasbani DJ; Lopes LC; Agarwal A; Guyatt G; Akl EA BMJ Open; 2016 Aug; 6(8):e011997. PubMed ID: 27515760 [TBL] [Abstract][Full Text] [Related]
25. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. Jørgensen AW; Hilden J; Gøtzsche PC BMJ; 2006 Oct; 333(7572):782. PubMed ID: 17028106 [TBL] [Abstract][Full Text] [Related]
26. Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results: A Systematic Review. Ito C; Hashimoto A; Uemura K; Oba K JAMA Netw Open; 2021 Dec; 4(12):e2135765. PubMed ID: 34874407 [TBL] [Abstract][Full Text] [Related]
27. Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials. Khan NA; Nguyen CL; Khawar T; Spencer H; Torralba KD Rheumatology (Oxford); 2019 May; 58(5):776-785. PubMed ID: 30535001 [TBL] [Abstract][Full Text] [Related]
28. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of and factors associated with potentially redundant randomized controlled trials: a cross-sectional study. Yun Q; Lin M; Jia Y; Wang Y; Zhang J; Sha F; Yang Z; Tang J J Clin Epidemiol; 2024 Mar; 167():111265. PubMed ID: 38266740 [TBL] [Abstract][Full Text] [Related]
30. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. Bero L; Oostvogel F; Bacchetti P; Lee K PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302 [TBL] [Abstract][Full Text] [Related]
31. Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study. Jones CW; Misemer BS; Platts-Mills TF; Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Keyhani S BMJ Open; 2018 Feb; 8(2):e019831. PubMed ID: 29439079 [TBL] [Abstract][Full Text] [Related]
32. Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses. Veroniki AA; Wong EKC; Lunny C; Martinez Molina JC; Florez ID; Tricco AC; Straus SE Syst Rev; 2023 May; 12(1):81. PubMed ID: 37149700 [TBL] [Abstract][Full Text] [Related]
33. Conflicts of interest and outcomes of clinical trials of antidepressants: An 18-year retrospective study. Waqas A; Baig AA; Khalid MA; Aedma KK; Naveed S J Psychiatr Res; 2019 Sep; 116():83-87. PubMed ID: 31212249 [TBL] [Abstract][Full Text] [Related]
34. Bias from industry trial funding? A framework, a suggested approach, and a negative result. Barden J; Derry S; McQuay HJ; Moore AR Pain; 2006 Apr; 121(3):207-218. PubMed ID: 16495012 [TBL] [Abstract][Full Text] [Related]
35. Association between research sponsorship and study outcome in plastic surgery literature. Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933 [TBL] [Abstract][Full Text] [Related]
36. Relationship between sponsorship and failure rate of dental implants: a systematic approach. Popelut A; Valet F; Fromentin O; Thomas A; Bouchard P PLoS One; 2010 Apr; 5(4):e10274. PubMed ID: 20422000 [TBL] [Abstract][Full Text] [Related]
37. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
38. Time trends in the reporting of conflicts of interest, funding and affiliation with industry in intensive care research: a systematic review. Darmon M; Helms J; De Jong A; Hjortrup PB; Weiss E; Granholm A; Pinciroli R; Poussardin C; Petersen MW; Sigaut S; Barreto BB; Moller MH; Azoulay E Intensive Care Med; 2018 Oct; 44(10):1669-1678. PubMed ID: 30141174 [TBL] [Abstract][Full Text] [Related]
39. Methodological quality of meta-analyses: matched-pairs comparison over time and between industry-sponsored and academic-sponsored reports. Lane PW; Higgins JP; Anagnostelis B; Anzures-Cabrera J; Baker NF; Cappelleri JC; Haughie S; Hollis S; Lewis SC; Moneuse P; Whitehead A Res Synth Methods; 2013 Dec; 4(4):342-50. PubMed ID: 26053947 [TBL] [Abstract][Full Text] [Related]
40. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]